Advertisement
Screener

Vivos Therapeutics, Inc. (VVOS) Debt Instrument, Face Amount

2.8 / 5 stars · 68/120 Roast Me

Vivos Therapeutics, Inc. Debt Instrument, Face Amount

Vivos Therapeutics, Inc. (VVOS) had Debt Instrument, Face Amount of $8.40 million as of 2026-06-30, per its 10-Q filed 2026-08-14.

Financial Statements › Notes › Debt › Debt Instruments

us-gaap:DebtInstrumentFaceAmount · last filed 2026-08-14

  • 2026-06-30: Debt Instrument, Face Amount $8.40M.
  • 2026-03-31: Debt Instrument, Face Amount $8.48M.
  • 2025-12-31: Debt Instrument, Face Amount $10.11M.
  • 2025-09-30: Debt Instrument, Face Amount $8.22M.
Period endDebt Instrument, Face Amount
2026-06-30$8.40M
10-Q · filed 2026-08-14
2026-03-31$8.48M
10-Q · filed 2026-05-20
2025-12-31$10.11M
10-Q · filed 2026-08-14
2025-09-30$8.22M
10-Q · filed 2025-11-19
2020-12-31$25.00K
10-Q · filed 2021-11-15
2020-05-08$1.30M
10-K · filed 2023-03-30
2019-12-31$25.00K
10-K · filed 2021-03-25

Similar stocks

Stock NameCountryMarket CapPE Ratio
Beyond Air, Inc. (XAIR)United States$0.003B-0.01
NEXGEL, INC. (NXGL)United States$0.002B
INVO Fertility, Inc. (IVF)United States$0.002B-0.71
Catheter Precision, Inc. (VTAK)United States$0.002B-0.23
Tenon Medical, Inc. (TNON)United States$0.002B
Autonomix Medical, Inc. (AMIX)United States$0.004B
Adagio Medical Holdings, Inc. (ADGM)United States$0.004B
Profusa, Inc. (PFSA)United States$0.002B
OSR Health, Inc. (OSRH)United States$0.004B-0.75
Bluejay Diagnostics, Inc. (BJDX)United States$0.004B